Independent executive consulting in advanced therapies, built on 20+ years of translating science into practice.
Get in touchScientific leadership across a broad range of cell therapy modalities — iPSC-derived and donor-derived, engineered and non-engineered, allogeneic and autologous. Strategy and hands-on execution from platform design through IND-enabling studies.
End-to-end CMC strategy and execution. Closed and automated bioprocessing, process scale-up and optimisation, COGS reduction, analytical development, and GMP manufacturing readiness.
Building and scaling multi-site development organisations. Facility design, CDMO selection and management, technology transfer, and operational infrastructure from early-stage through clinical supply. Deploying AI and digital tools to streamline development workflows, accelerate decision-making, and reduce time to clinic.
Regulatory strategy shaped by Quality-by-Design thinking: building flexibility, deep process knowledge, and alignment with evolving agency expectations. Investor engagement, due diligence support, and the operational credibility that turns a science story into a fundable programme.
Over a decade of VP and C-suite leadership across cell and gene therapy companies, spanning R&D strategy and execution, CMC development, process scale-up, technical operations, and organisational leadership. Built on a further decade of in-the-trenches execution and deep technical expertise.
That experience ranges from guiding startups through their first hires, first facilities, and first regulatory milestones, to architecting manufacturing platforms and CMC strategies with a commercial endpoint in mind. I understand what it takes to help a company evolve from a compelling scientific idea into a structured, investable, and operationally credible organisation.
I operate as an independent consultant and fractional executive through logix.bio, partnering with biotech organisations on challenges where science, manufacturing, and strategy converge. I'm driven by creative problem-solving: questioning assumptions, challenging dogma, and finding unconventional paths through complex technical and strategic landscapes. Whether it's building a CMC function from scratch, designing a manufacturing platform, deploying AI tools to accelerate development workflows, or supporting a company through Series A, I bring both hands-on technical depth and executive perspective.
Whether you have a specific challenge in mind or want to explore how I might support your organisation, I'd welcome a conversation.